Home » Topics » Regulatory

Regulatory
RSS

Camptosar approved in Canada as first-line treatment of metastatic colorectal cancer

March 29, 2001

Intravenous formulation of Protonix approved by FDA for GERD

March 29, 2001

Enrollment closed in Atrix's phase III trial with four-month Leuprogel

March 29, 2001

Cyamemazine reported to successfully substitute for benzodiazepines

March 27, 2001

Pharmaceutical compositions for obstructive airways disorders claimed by AstraZeneca

March 27, 2001

Expanded use of Visudyne approved in E.U.

March 27, 2001

Schering-Plough receives notification of priority review status for PEG-Intron/Rebetol sBLA

March 27, 2001

Roche seeks FDA approval for Xenical as adjunct in type 2 diabetes

March 23, 2001

Two new antiglaucoma drugs approved by FDA

March 19, 2001

Abbott and NaPro BioTherapeutics file ANDA for paclitaxel

March 19, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...